Clinical Efficacy and Safety Evaluation of Paclitaxel and Cisplatin Combined with Anlotinib Chemotherapy Regimen in Advanced Lung Adenocarcinoma Patients

SHEN Hui; CHEN Qian; ZHAO Liang

doi:10.14033/j.cnki.cfmr.2023.18.006

Home>Articles>Clinical Efficacy and Safety Evaluation of Paclitaxel and Cisplatin Combined with Anlotinib Chemotherapy Regimen in Advanced Lung Adenocarcinoma Patients

DOI: 10.14033/j.cnki.cfmr.2023.18.006

Clinical Efficacy and Safety Evaluation of Paclitaxel and Cisplatin Combined with Anlotinib Chemotherapy Regimen in Advanced Lung Adenocarcinoma Patients

SHEN Hui

CHEN Qian

ZHAO Liang

Keywords：Lung adenocarcinomaPaclitaxelCisplatinAnlotinibAdverse reactionsTumor markers

Publication Date：2023-06-25

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：4( 22-25 )

Chinese and Foreign Medical Research

ISSN：1674-6805

Year, Vol.(Issue)：2023,21(18)